Global Automation in Biopharma Industry Market Size study & Forecast, by Technology (Automation Technology, Digitization Technology), by Application (Clinical Phase, Drug Discovery Phase, Production Phase), by Component (Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase), by Automation Technology (Supervisory Control and Data Acquisition (SCADA), Distributed Control Systems (DCS), Programmable Logic Controllers (PLC), Manufacturing Execution System (MES), Human-machine Interface (HMI), Advanced Process Control (APC), Others) by Digitization Technology (Internet of things (IoT), Artificial Intelligence (AI), Digital Twin Technology, Augmented Reality (AR) and Virtual Reality (VR), Predictive Analytics, Cloud Computing) and Regional Analysis, 2023-2030
Global Automation in Biopharma Industry Market is valued at approximately USD 1784.1 million in 2022 and is anticipated to grow with a healthy growth rate of more than 5.7% over the forecast period 2023-2030. Automation in the biopharma industry refers to the use of advanced technologies and software to automate various processes in the biopharmaceutical manufacturing and research sector. This includes automation of laboratory workflows, manufacturing processes, quality control, and data analysis. Automation in the biopharma industry aims to improve the efficiency, speed, and accuracy of these processes while also reducing errors and minimizing human intervention. The automation can involve the use of robots, sensors, artificial intelligence, and other advanced technologies to streamline the production process and increase productivity. The market growth is driven by key factors such as technological Advancements to Improve Product Safety and increasing need for machine flexibility.
Pharmaceutical companies stated they planned to adopt automated solutions more frequently, to the extent of 75%. Along with a lack of available labor, this is primarily driven by the trend toward injectables and more customized medications. Customized doses and products like pre-filled syringes put a strain on pharmaceutical production systems. In addition, there has been a surge in demand for telehealth and telemedicine after the Covid-19 epidemic began in 2020. Telemedicine primarily focuses on remote clinical services, but telehealth also covers remote non-clinical services. Since the pandemic, more individuals have adopted new working and living practices; as a result, this trend is anticipated to continue gaining speed. By 2026, it is predicted that the worldwide telemedicine industry would expand from $68.36 billion to $218.49 billion. Furthermore, EndeavorRx, which received FDA clearance in 2020, is the first and only video game therapy. The game, which requires a prescription, is meant to help youngsters with ADHD who are 8 to 12 years old increase their attention span. 73% of participants in clinical investigations stated their ability to pay attention had improved. Moreover, robotics is Valuable for Biopharma Operations, and research and Development Through Automation of Lab Processes are opportunities to enhance the market growth in the projected period. However, High Initial Investment Costs stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Automation in Biopharma Industry Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is dominating the market growth owing to the expansion of the pharmaceutical automation market in the N will be aided by the development of R&D facilities for the manufacturing of therapeutic drugs and expertise in novel drug formulation, as well as the region's growing geriatric population and incidence of chronic illnesses.
Major market player included in this report are:
PerkinElmer, Inc.
AMETEK, Inc.
Autodesk, Inc.
Baumueller-Nuermont Corp
Emerson Electric Co.
Kawasaki Robotics
RheoSense Inc.
Rockwell Automation, Inc.
Sartorius Stedim Biotech SA
Siemens Healthineers
Recent Developments in the Market:
February 2023, Siemens Healthineers and Unilabs agreed to a multi-year for more than USD 212.3 million. To upgrade its laboratory infrastructure and offer unmatched client service, Unilabs has invested in top-tier Siemens Healthineers technology and will purchase more than 400 laboratory analyzers.
In September 2022, Cellaca® PLX Image Cytometry System was unveiled by PerkinElmer, Inc. It is a groundbreaking benchtop platform that enables researchers to evaluate numerous Critical Quality Attributes (CQAs) of cell samples in a single automated process, including cell identification, quality, and number.
Global Automation in Biopharma Industry Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Technology, Application, Component, Automation Technology, Digitization Technology, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Automation Technology
Digitization Technology
By Application:
Clinical Phase
Drug Discovery Phase
Production Phase
By Component:
Automation Hardware
Automation Software
Services Project Phase
Services Operation Phase
By Automation Technology:
Supervisory Control and Data Acquisition (SCADA)
Distributed Control Systems (DCS)
Programmable Logic Controllers (PLC)
Manufacturing Execution System (MES)
Human-machine Interface (HMI)
Advanced Process Control (APC)
Others
By Digitization Technology:
Internet of things (IoT)
Artificial Intelligence (AI)
Digital Twin Technology
Augmented Reality (AR) and Virtual Reality (VR)
Predictive Analytics
Cloud Computing
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Pharmaceutical companies stated they planned to adopt automated solutions more frequently, to the extent of 75%. Along with a lack of available labor, this is primarily driven by the trend toward injectables and more customized medications. Customized doses and products like pre-filled syringes put a strain on pharmaceutical production systems. In addition, there has been a surge in demand for telehealth and telemedicine after the Covid-19 epidemic began in 2020. Telemedicine primarily focuses on remote clinical services, but telehealth also covers remote non-clinical services. Since the pandemic, more individuals have adopted new working and living practices; as a result, this trend is anticipated to continue gaining speed. By 2026, it is predicted that the worldwide telemedicine industry would expand from $68.36 billion to $218.49 billion. Furthermore, EndeavorRx, which received FDA clearance in 2020, is the first and only video game therapy. The game, which requires a prescription, is meant to help youngsters with ADHD who are 8 to 12 years old increase their attention span. 73% of participants in clinical investigations stated their ability to pay attention had improved. Moreover, robotics is Valuable for Biopharma Operations, and research and Development Through Automation of Lab Processes are opportunities to enhance the market growth in the projected period. However, High Initial Investment Costs stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Automation in Biopharma Industry Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is dominating the market growth owing to the expansion of the pharmaceutical automation market in the N will be aided by the development of R&D facilities for the manufacturing of therapeutic drugs and expertise in novel drug formulation, as well as the region's growing geriatric population and incidence of chronic illnesses.
Major market player included in this report are:
PerkinElmer, Inc.
AMETEK, Inc.
Autodesk, Inc.
Baumueller-Nuermont Corp
Emerson Electric Co.
Kawasaki Robotics
RheoSense Inc.
Rockwell Automation, Inc.
Sartorius Stedim Biotech SA
Siemens Healthineers
Recent Developments in the Market:
February 2023, Siemens Healthineers and Unilabs agreed to a multi-year for more than USD 212.3 million. To upgrade its laboratory infrastructure and offer unmatched client service, Unilabs has invested in top-tier Siemens Healthineers technology and will purchase more than 400 laboratory analyzers.
In September 2022, Cellaca® PLX Image Cytometry System was unveiled by PerkinElmer, Inc. It is a groundbreaking benchtop platform that enables researchers to evaluate numerous Critical Quality Attributes (CQAs) of cell samples in a single automated process, including cell identification, quality, and number.
Global Automation in Biopharma Industry Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Technology, Application, Component, Automation Technology, Digitization Technology, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Automation Technology
Digitization Technology
By Application:
Clinical Phase
Drug Discovery Phase
Production Phase
By Component:
Automation Hardware
Automation Software
Services Project Phase
Services Operation Phase
By Automation Technology:
Supervisory Control and Data Acquisition (SCADA)
Distributed Control Systems (DCS)
Programmable Logic Controllers (PLC)
Manufacturing Execution System (MES)
Human-machine Interface (HMI)
Advanced Process Control (APC)
Others
By Digitization Technology:
Internet of things (IoT)
Artificial Intelligence (AI)
Digital Twin Technology
Augmented Reality (AR) and Virtual Reality (VR)
Predictive Analytics
Cloud Computing
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Automation in Biopharma Industry Market, by Region, 2020-2030 (USD Million)
1.2.2. Automation in Biopharma Industry Market, by Technology, 2020-2030 (USD Million)
1.2.3. Automation in Biopharma Industry Market, by Application, 2020-2030 (USD Million)
1.2.4. Automation in Biopharma Industry Market, by Component, 2020-2030 (USD Million)
1.2.5. Automation in Biopharma Industry Market, by Automation Technology, 2020-2030 (USD Million)
1.2.6. Automation in Biopharma Industry Market, by Digitization Technology, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET DYNAMICS
3.1. Automation in Biopharma Industry Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Technological Advancements to Improve Product Safety
3.1.1.2. Increasing Need for Machine Flexibility
3.1.2. Market Challenges
3.1.2.1. High Initial Investment Costs
3.1.3. Market Opportunities
3.1.3.1. Robotics is Valuable for Biopharma Operations
3.1.3.2. Research and Development Through Automation of Lab Processes
CHAPTER 4. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET, BY TECHNOLOGY
5.1. Market Snapshot
5.2. Global Automation in Biopharma Industry Market by Technology, Performance - Potential Analysis
5.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Technology 2020-2030 (USD Million)
5.4. Automation in Biopharma Industry Market, Sub Segment Analysis
5.4.1. Automation Technology
5.4.2. Digitisation Technology
CHAPTER 6. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Automation in Biopharma Industry Market by Application, Performance - Potential Analysis
6.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Application 2020-2030 (USD Million)
6.4. Automation in Biopharma Industry Market, Sub Segment Analysis
6.4.1. Clinical Phase
6.4.2. Drug Discovery Phase
6.4.3. Production Phase
CHAPTER 7. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET, BY COMPONENT
7.1. Market Snapshot
7.2. Global Automation in Biopharma Industry Market by Component, Performance - Potential Analysis
7.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Component 2020-2030 (USD Million)
7.4. Automation in Biopharma Industry Market, Sub Segment Analysis
7.4.1. Automation Hardware
7.4.2. Automation Software
7.4.3. Services Project Phase
7.4.4. Services Operation Phase
CHAPTER 8. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET, BY AUTOMATION TECHNOLOGY
8.1. Market Snapshot
8.2. Global Automation in Biopharma Industry Market by Automation Technology, Performance - Potential Analysis
8.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Automation Technology 2020-2030 (USD Million)
8.4. Automation in Biopharma Industry Market, Sub Segment Analysis
8.4.1. Supervisory Control and Data Acquisition (SCADA)
8.4.2. Distributed Control Systems (DCS)
8.4.3. Programmable Logic Controllers (PLC)
8.4.4. Manufacturing Execution System (MES)
8.4.5. Human-machine Interface (HMI)
8.4.6. Advanced Process Control (APC)
8.4.7. Others
CHAPTER 9. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET, BY DIGITIZATION TECHNOLOGY
9.1. Market Snapshot
9.2. Global Automation in Biopharma Industry Market by Digitization Technology, Performance - Potential Analysis
9.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Digitization Technology 2020-2030 (USD Million)
9.4. Automation in Biopharma Industry Market, Sub Segment Analysis
9.4.1. Internet of things (IoT)
9.4.2. Artificial Intelligence (AI)
9.4.3. Digital Twin Technology
9.4.4. Augmented Reality (AR) and Virtual Reality (VR)
9.4.5. Predictive Analytics
9.4.6. Cloud Computing
CHAPTER 10. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET, REGIONAL ANALYSIS
10.1. Top Leading Countries
10.2. Top Emerging Countries
10.3. Automation in Biopharma Industry Market, Regional Market Snapshot
10.4. North America Automation in Biopharma Industry Market
10.4.1. U.S. Automation in Biopharma Industry Market
10.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
10.4.1.2. Application breakdown estimates & forecasts, 2020-2030
10.4.1.3. Component breakdown estimates & forecasts, 2020-2030
10.4.1.4. Automation Technology breakdown estimates & forecasts, 2020-2030
10.4.1.5. Digitization Technology breakdown estimates & forecasts, 2020-2030
10.4.2. Canada Automation in Biopharma Industry Market
10.5. Europe Automation in Biopharma Industry Market Snapshot
10.5.1. U.K. Automation in Biopharma Industry Market
10.5.2. Germany Automation in Biopharma Industry Market
10.5.3. France Automation in Biopharma Industry Market
10.5.4. Spain Automation in Biopharma Industry Market
10.5.5. Italy Automation in Biopharma Industry Market
10.5.6. Rest of Europe Automation in Biopharma Industry Market
10.6. Asia-Pacific Automation in Biopharma Industry Market Snapshot
10.6.1. China Automation in Biopharma Industry Market
10.6.2. India Automation in Biopharma Industry Market
10.6.3. Japan Automation in Biopharma Industry Market
10.6.4. Australia Automation in Biopharma Industry Market
10.6.5. South Korea Automation in Biopharma Industry Market
10.6.6. Rest of Asia Pacific Automation in Biopharma Industry Market
10.7. Latin America Automation in Biopharma Industry Market Snapshot
10.7.1. Brazil Automation in Biopharma Industry Market
10.7.2. Mexico Automation in Biopharma Industry Market
10.8. Middle East & Africa Automation in Biopharma Industry Market
10.8.1. Saudi Arabia Automation in Biopharma Industry Market
10.8.2. South Africa Automation in Biopharma Industry Market
10.8.3. Rest of Middle East & Africa Automation in Biopharma Industry Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Key Company SWOT Analysis
11.1.1. Company
11.1.2. Company
11.1.3. Company
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. PerkinElmer, Inc.
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Recent Developments
11.3.2. AMETEK, Inc.
11.3.3. Autodesk, Inc.
11.3.4. Baumueller-Nuermont Corp
11.3.5. Emerson Electric Co.
11.3.6. Kawasaki Robotics
11.3.7. RheoSense Inc.
11.3.8. Rockwell Automation, Inc.
11.3.9. Sartorius Stedim Biotech SA
11.3.10. Siemens Healthineers
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Automation in Biopharma Industry Market, by Region, 2020-2030 (USD Million)
1.2.2. Automation in Biopharma Industry Market, by Technology, 2020-2030 (USD Million)
1.2.3. Automation in Biopharma Industry Market, by Application, 2020-2030 (USD Million)
1.2.4. Automation in Biopharma Industry Market, by Component, 2020-2030 (USD Million)
1.2.5. Automation in Biopharma Industry Market, by Automation Technology, 2020-2030 (USD Million)
1.2.6. Automation in Biopharma Industry Market, by Digitization Technology, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET DYNAMICS
3.1. Automation in Biopharma Industry Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Technological Advancements to Improve Product Safety
3.1.1.2. Increasing Need for Machine Flexibility
3.1.2. Market Challenges
3.1.2.1. High Initial Investment Costs
3.1.3. Market Opportunities
3.1.3.1. Robotics is Valuable for Biopharma Operations
3.1.3.2. Research and Development Through Automation of Lab Processes
CHAPTER 4. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET, BY TECHNOLOGY
5.1. Market Snapshot
5.2. Global Automation in Biopharma Industry Market by Technology, Performance - Potential Analysis
5.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Technology 2020-2030 (USD Million)
5.4. Automation in Biopharma Industry Market, Sub Segment Analysis
5.4.1. Automation Technology
5.4.2. Digitisation Technology
CHAPTER 6. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Automation in Biopharma Industry Market by Application, Performance - Potential Analysis
6.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Application 2020-2030 (USD Million)
6.4. Automation in Biopharma Industry Market, Sub Segment Analysis
6.4.1. Clinical Phase
6.4.2. Drug Discovery Phase
6.4.3. Production Phase
CHAPTER 7. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET, BY COMPONENT
7.1. Market Snapshot
7.2. Global Automation in Biopharma Industry Market by Component, Performance - Potential Analysis
7.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Component 2020-2030 (USD Million)
7.4. Automation in Biopharma Industry Market, Sub Segment Analysis
7.4.1. Automation Hardware
7.4.2. Automation Software
7.4.3. Services Project Phase
7.4.4. Services Operation Phase
CHAPTER 8. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET, BY AUTOMATION TECHNOLOGY
8.1. Market Snapshot
8.2. Global Automation in Biopharma Industry Market by Automation Technology, Performance - Potential Analysis
8.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Automation Technology 2020-2030 (USD Million)
8.4. Automation in Biopharma Industry Market, Sub Segment Analysis
8.4.1. Supervisory Control and Data Acquisition (SCADA)
8.4.2. Distributed Control Systems (DCS)
8.4.3. Programmable Logic Controllers (PLC)
8.4.4. Manufacturing Execution System (MES)
8.4.5. Human-machine Interface (HMI)
8.4.6. Advanced Process Control (APC)
8.4.7. Others
CHAPTER 9. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET, BY DIGITIZATION TECHNOLOGY
9.1. Market Snapshot
9.2. Global Automation in Biopharma Industry Market by Digitization Technology, Performance - Potential Analysis
9.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Digitization Technology 2020-2030 (USD Million)
9.4. Automation in Biopharma Industry Market, Sub Segment Analysis
9.4.1. Internet of things (IoT)
9.4.2. Artificial Intelligence (AI)
9.4.3. Digital Twin Technology
9.4.4. Augmented Reality (AR) and Virtual Reality (VR)
9.4.5. Predictive Analytics
9.4.6. Cloud Computing
CHAPTER 10. GLOBAL AUTOMATION IN BIOPHARMA INDUSTRY MARKET, REGIONAL ANALYSIS
10.1. Top Leading Countries
10.2. Top Emerging Countries
10.3. Automation in Biopharma Industry Market, Regional Market Snapshot
10.4. North America Automation in Biopharma Industry Market
10.4.1. U.S. Automation in Biopharma Industry Market
10.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
10.4.1.2. Application breakdown estimates & forecasts, 2020-2030
10.4.1.3. Component breakdown estimates & forecasts, 2020-2030
10.4.1.4. Automation Technology breakdown estimates & forecasts, 2020-2030
10.4.1.5. Digitization Technology breakdown estimates & forecasts, 2020-2030
10.4.2. Canada Automation in Biopharma Industry Market
10.5. Europe Automation in Biopharma Industry Market Snapshot
10.5.1. U.K. Automation in Biopharma Industry Market
10.5.2. Germany Automation in Biopharma Industry Market
10.5.3. France Automation in Biopharma Industry Market
10.5.4. Spain Automation in Biopharma Industry Market
10.5.5. Italy Automation in Biopharma Industry Market
10.5.6. Rest of Europe Automation in Biopharma Industry Market
10.6. Asia-Pacific Automation in Biopharma Industry Market Snapshot
10.6.1. China Automation in Biopharma Industry Market
10.6.2. India Automation in Biopharma Industry Market
10.6.3. Japan Automation in Biopharma Industry Market
10.6.4. Australia Automation in Biopharma Industry Market
10.6.5. South Korea Automation in Biopharma Industry Market
10.6.6. Rest of Asia Pacific Automation in Biopharma Industry Market
10.7. Latin America Automation in Biopharma Industry Market Snapshot
10.7.1. Brazil Automation in Biopharma Industry Market
10.7.2. Mexico Automation in Biopharma Industry Market
10.8. Middle East & Africa Automation in Biopharma Industry Market
10.8.1. Saudi Arabia Automation in Biopharma Industry Market
10.8.2. South Africa Automation in Biopharma Industry Market
10.8.3. Rest of Middle East & Africa Automation in Biopharma Industry Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Key Company SWOT Analysis
11.1.1. Company
11.1.2. Company
11.1.3. Company
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. PerkinElmer, Inc.
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Recent Developments
11.3.2. AMETEK, Inc.
11.3.3. Autodesk, Inc.
11.3.4. Baumueller-Nuermont Corp
11.3.5. Emerson Electric Co.
11.3.6. Kawasaki Robotics
11.3.7. RheoSense Inc.
11.3.8. Rockwell Automation, Inc.
11.3.9. Sartorius Stedim Biotech SA
11.3.10. Siemens Healthineers
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Automation in Biopharma Industry Market, report scope
TABLE 2. Global Automation in Biopharma Industry Market estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Automation in Biopharma Industry Market estimates & forecasts by Technology 2020-2030 (USD Million)
TABLE 4. Global Automation in Biopharma Industry Market estimates & forecasts by Application 2020-2030 (USD Million)
TABLE 5. Global Automation in Biopharma Industry Market estimates & forecasts by Component 2020-2030 (USD Million)
TABLE 6. Global Automation in Biopharma Industry Market estimates & forecasts by Automation Technology 2020-2030 (USD Million)
TABLE 7. Global Automation in Biopharma Industry Market estimates & forecasts by Digitization Technology 2020-2030 (USD Million)
TABLE 8. Global Automation in Biopharma Industry Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Automation in Biopharma Industry Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Automation in Biopharma Industry Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Automation in Biopharma Industry Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Automation in Biopharma Industry Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Automation in Biopharma Industry Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Automation in Biopharma Industry Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. Global Automation in Biopharma Industry Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. Global Automation in Biopharma Industry Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 17. Global Automation in Biopharma Industry Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 18. U.S. Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 19. U.S. Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 20. U.S. Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 21. Canada Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 22. Canada Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 23. Canada Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 24. UK Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 25. UK Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 26. UK Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 27. Germany Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 28. Germany Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 29. Germany Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 30. France Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 31. France Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 32. France Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 33. Italy Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 34. Italy Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 35. Italy Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 36. Spain Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 37. Spain Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 38. Spain Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 39. RoE Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 40. RoE Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 41. RoE Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 42. China Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 43. China Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 44. China Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 45. India Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 46. India Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 47. India Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 48. Japan Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 49. Japan Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 50. Japan Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 51. South Korea Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 52. South Korea Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 53. South Korea Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 54. Australia Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 55. Australia Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 56. Australia Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 57. RoAPAC Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 58. RoAPAC Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 59. RoAPAC Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 60. Brazil Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 61. Brazil Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 62. Brazil Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 63. Mexico Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 64. Mexico Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 65. Mexico Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 66. RoLA Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 67. RoLA Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 68. RoLA Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 69. Saudi Arabia Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 70. South Africa Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 71. RoMEA Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 72. List of secondary sources, used in the study of global Automation in Biopharma Industry Market
TABLE 73. List of primary sources, used in the study of global Automation in Biopharma Industry Market
TABLE 74. Years considered for the study
TABLE 75. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Automation in Biopharma Industry Market, report scope
TABLE 2. Global Automation in Biopharma Industry Market estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Automation in Biopharma Industry Market estimates & forecasts by Technology 2020-2030 (USD Million)
TABLE 4. Global Automation in Biopharma Industry Market estimates & forecasts by Application 2020-2030 (USD Million)
TABLE 5. Global Automation in Biopharma Industry Market estimates & forecasts by Component 2020-2030 (USD Million)
TABLE 6. Global Automation in Biopharma Industry Market estimates & forecasts by Automation Technology 2020-2030 (USD Million)
TABLE 7. Global Automation in Biopharma Industry Market estimates & forecasts by Digitization Technology 2020-2030 (USD Million)
TABLE 8. Global Automation in Biopharma Industry Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Automation in Biopharma Industry Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Automation in Biopharma Industry Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Automation in Biopharma Industry Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Automation in Biopharma Industry Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Automation in Biopharma Industry Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Automation in Biopharma Industry Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. Global Automation in Biopharma Industry Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. Global Automation in Biopharma Industry Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 17. Global Automation in Biopharma Industry Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 18. U.S. Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 19. U.S. Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 20. U.S. Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 21. Canada Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 22. Canada Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 23. Canada Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 24. UK Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 25. UK Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 26. UK Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 27. Germany Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 28. Germany Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 29. Germany Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 30. France Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 31. France Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 32. France Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 33. Italy Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 34. Italy Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 35. Italy Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 36. Spain Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 37. Spain Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 38. Spain Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 39. RoE Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 40. RoE Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 41. RoE Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 42. China Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 43. China Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 44. China Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 45. India Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 46. India Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 47. India Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 48. Japan Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 49. Japan Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 50. Japan Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 51. South Korea Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 52. South Korea Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 53. South Korea Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 54. Australia Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 55. Australia Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 56. Australia Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 57. RoAPAC Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 58. RoAPAC Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 59. RoAPAC Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 60. Brazil Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 61. Brazil Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 62. Brazil Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 63. Mexico Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 64. Mexico Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 65. Mexico Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 66. RoLA Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 67. RoLA Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 68. RoLA Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 69. Saudi Arabia Automation in Biopharma Industry Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 70. South Africa Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 71. RoMEA Automation in Biopharma Industry Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 72. List of secondary sources, used in the study of global Automation in Biopharma Industry Market
TABLE 73. List of primary sources, used in the study of global Automation in Biopharma Industry Market
TABLE 74. Years considered for the study
TABLE 75. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Automation in Biopharma Industry Market, research methodology
FIG 2. Global Automation in Biopharma Industry Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Automation in Biopharma Industry Market, key trends 2022
FIG 5. Global Automation in Biopharma Industry Market, growth prospects 2023-2030
FIG 6. Global Automation in Biopharma Industry Market, porters 5 force model
FIG 7. Global Automation in Biopharma Industry Market, pest analysis
FIG 8. Global Automation in Biopharma Industry Market, value chain analysis
FIG 9. Global Automation in Biopharma Industry Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Automation in Biopharma Industry Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Automation in Biopharma Industry Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Automation in Biopharma Industry Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Automation in Biopharma Industry Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Automation in Biopharma Industry Market, regional snapshot 2020 & 2030
FIG 15. North America Automation in Biopharma Industry Market 2020 & 2030 (USD Million)
FIG 16. Europe Automation in Biopharma Industry Market 2020 & 2030 (USD Million)
FIG 17. Asia pacific Automation in Biopharma Industry Market 2020 & 2030 (USD Million)
FIG 18. Latin America Automation in Biopharma Industry Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Automation in Biopharma Industry Market 2020 & 2030 (USD Million)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Automation in Biopharma Industry Market, research methodology
FIG 2. Global Automation in Biopharma Industry Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Automation in Biopharma Industry Market, key trends 2022
FIG 5. Global Automation in Biopharma Industry Market, growth prospects 2023-2030
FIG 6. Global Automation in Biopharma Industry Market, porters 5 force model
FIG 7. Global Automation in Biopharma Industry Market, pest analysis
FIG 8. Global Automation in Biopharma Industry Market, value chain analysis
FIG 9. Global Automation in Biopharma Industry Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Automation in Biopharma Industry Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Automation in Biopharma Industry Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Automation in Biopharma Industry Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Automation in Biopharma Industry Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Automation in Biopharma Industry Market, regional snapshot 2020 & 2030
FIG 15. North America Automation in Biopharma Industry Market 2020 & 2030 (USD Million)
FIG 16. Europe Automation in Biopharma Industry Market 2020 & 2030 (USD Million)
FIG 17. Asia pacific Automation in Biopharma Industry Market 2020 & 2030 (USD Million)
FIG 18. Latin America Automation in Biopharma Industry Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Automation in Biopharma Industry Market 2020 & 2030 (USD Million)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
